Portfolio News Versa Vascular Christine Johnson 12/8/25 Versa Vascular Christine Johnson 12/8/25 Versa Vascular Secures $27.3M Oversubscribed Series C Funding and Appoints David Hovda as CEO to Advance Novel Tricuspid Valve Repair Technology Read More
Versa Vascular Christine Johnson 12/8/25 Versa Vascular Christine Johnson 12/8/25 Versa Vascular Secures $27.3M Oversubscribed Series C Funding and Appoints David Hovda as CEO to Advance Novel Tricuspid Valve Repair Technology Read More
